Acquisitions Of Aculab And Margento Will Expand Services In High-Demand Sectors

Shared on01 May 25
Fair value Decreased 10%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 2.30%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 8.44%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 0.84%

AnalystConsensusTarget has decreased revenue growth from 5.9% to 5.1%.

Shared on13 Mar 25
Fair value Increased 17%

AnalystConsensusTarget has decreased profit margin from 17.1% to 14.2% and increased future PE multiple from 21.4x to 24.2x.